111

ANYGEN CO., LTD.

No trades
See on Supercharts

196300 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

ANYGEN Co., Ltd. engages in the development and production of therapeutic peptides. It operates through the following business divisions: Medicinal Peptide Materials, Research Peptide Materials, and Product and Technology Fees. The Medicinal Peptide Materials division includes leuprolin, desmopressin, and clinical peptides. The Research Peptide Materials division offers custom peptides for research and development. The Product and Technology Fees division deals with chemical library. The company was founded on May 2, 2000 and is headquartered in Gwangju, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

196300 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company